Sulfasalazine

sulfasalazine and is a safe, well-established, and endowed with well-known anti-inflammatory and immune that was used for decades in the treatment of inflammatory diseases of the intestine. Was later discovered to have a positive effect on rheumatoid arthritis. Recently, we published the results of a collaborative study of the third stage, double-blind, placebo-controlled study from the Mayo Clinic, Canada's sulfasalazine in the treatment of Active MS. 99 patients were treated in the emergency percent with active MS with sulfasalazine (up to 2 g / day) or placebo, and observed for at least three years (mean follow-up 3.7 years). Although the short-term response has (2 years) preferential treatment can prevent or slow the progression of disability by the primary endpoint measure appeared (confirmed worsening EDSS one point at least for a period of consecutive examinations at intervals of 3 months).